#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4029647	B	Inhibition of full length recombinant mouse N-terminal GST-tagged PAD2 expressed in baculovirus infected Sf9 cells using benzoyl arginine ethyl ester as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by colorimetric assay	Mus musculus	5		cell-based format	Scientific Literature
2.	ALA4029648	B	Inhibition of full length recombinant human N-terminal GST-tagged PAD4 expressed in baculovirus infected Sf9 cells using benzoyl arginine ethylester as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by colorimetric assay	Homo sapiens	5		cell-based format	Scientific Literature
3.	ALA4029649	B	Inhibition of human PAD1 using BAEE as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by colorimetric assay	Homo sapiens	4		single protein format	Scientific Literature
4.	ALA4029650	F	Antiinflammatory activity in MOG peptide/complete freund's adjuvant/pertussis toxin-induced C57BL/6 mouse autoimmune encephalomyelitis model assessed as improvement in physical disability at 100 mg/kg, ip administered once daily for 40 days measured daily during compound dosing	Mus musculus	3		organism-based format	Scientific Literature
5.	ALA4029653	F	Antiinflammatory activity in MOG peptide/complete freund's adjuvant/pertussis toxin-induced C57BL/6 mouse autoimmune encephalomyelitis model assessed as reduction in accumulation of CD3 positive cells in brain at 100 mg/kg, ip administered once daily for 40 days measured post last dose	Mus musculus	2		organism-based format	Scientific Literature
6.	ALA4029654	F	Antiinflammatory activity in MOG peptide/complete freund's adjuvant/pertussis toxin-induced C57BL/6 mouse autoimmune encephalomyelitis model assessed as reduction in accumulation of MAC3 positive cells in brain at 100 mg/kg, ip administered once daily for 40 days measured post last dose	Mus musculus	2		organism-based format	Scientific Literature
7.	ALA4029672	T	Toxicity in MOG peptide/complete freund's adjuvant/pertussis toxin-induced C57BL/6 mouse autoimmune encephalomyelitis model assessed as death at 100 mg/kg, ip administered once daily for 40 days measured during compound dosing (Rvb = 21%)	Mus musculus	2		organism-based format	Scientific Literature
8.	ALA4029674	F	Antiinflammatory activity in MOG peptide/complete freund's adjuvant/pertussis toxin-induced C57BL/6 mouse autoimmune encephalomyelitis model assessed as reduction in inflammatory lesions in brain at 100 mg/kg, ip administered once daily for 40 days measured post last dose by hematoxylin and eosin/Luxol-fast blue staining based assay	Mus musculus	2		organism-based format	Scientific Literature
9.	ALA4029675	T	Toxicity in MOG peptide/complete freund's adjuvant/pertussis toxin-induced C57BL/6 mouse autoimmune encephalomyelitis model assessed as change in body weight at 100 mg/kg, ip administered once daily for 40 days measured during compound dosing	Mus musculus	3		organism-based format	Scientific Literature